Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burlingame

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
International Journal of Group Psychotherapy|September 25, 2004
Group interventions for patients with cancer and HIV disease: part IV. Clinical and policy recommendationsMolyn Leszcz, Allen Sherman, Julie Mosier, et al.
International Journal of Group Psychotherapy|April 24, 2004
Group interventions for patients with cancer and HIV disease: Part II. Effects on immune, endocrine, and disease outcomes at different phases of illnessAllen C Sherman, Molyn Leszcz, Julie Mosier, et al.
International Journal of Group Psychotherapy|February 28, 2004
Group interventions for patients with cancer and HIV disease: Part I: Effects on psychosocial and functional outcomes at different phases of illnessAllen C Sherman, Julie Mosier, Molyn Leszcz, et al.
Cancer Research|February 28, 2002
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastomaJason M Shohet, M John Hicks, Sharon E Plon, et al.
International Journal of Group Psychotherapy|July 16, 2004
Group interventions for patients with cancer and HIV disease: Part III. Moderating variables and mechanisms of actionAllen C Sherman, Julie Mosier, Molyn Leszcz, et al.
Molecular Cancer Therapeutics|August 13, 2009
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastomaXiaoying Shang, Susan M Burlingame, M Fatih Okcu, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 31, 2008
Effectiveness of a school-based group psychotherapy program for war-exposed adolescents: a randomized controlled trialChristopher M Layne, William R Saltzman, Landon Poppleton, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
International Journal of Group Psychotherapy|September 25, 2004
Group interventions for patients with cancer and HIV disease: part IV. Clinical and policy recommendationsMolyn Leszcz, Allen Sherman, Julie Mosier, et al.
International Journal of Group Psychotherapy|April 24, 2004
Group interventions for patients with cancer and HIV disease: Part II. Effects on immune, endocrine, and disease outcomes at different phases of illnessAllen C Sherman, Molyn Leszcz, Julie Mosier, et al.
International Journal of Group Psychotherapy|February 28, 2004
Group interventions for patients with cancer and HIV disease: Part I: Effects on psychosocial and functional outcomes at different phases of illnessAllen C Sherman, Julie Mosier, Molyn Leszcz, et al.
Cancer Research|February 28, 2002
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastomaJason M Shohet, M John Hicks, Sharon E Plon, et al.
International Journal of Group Psychotherapy|July 16, 2004
Group interventions for patients with cancer and HIV disease: Part III. Moderating variables and mechanisms of actionAllen C Sherman, Julie Mosier, Molyn Leszcz, et al.
Molecular Cancer Therapeutics|August 13, 2009
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastomaXiaoying Shang, Susan M Burlingame, M Fatih Okcu, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 31, 2008
Effectiveness of a school-based group psychotherapy program for war-exposed adolescents: a randomized controlled trialChristopher M Layne, William R Saltzman, Landon Poppleton, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
Pageof 8